The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...

Gelteq Limited ('Gelteq” or the 'Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, ...

Investing.com -- Gelteq Limited (ASX:GTQ) stock gained 2.7% on Friday after the company announced promising preclinical results for its proprietary gel-based oral delivery technology, demonstrating ...

PeptiDream Inc. ( OTCPK:PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline December 5, 2025 1:30 AM EST ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that ...

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a ...

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...

Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors Matthew Baker appointed as CEOLaigo Bio’s SureTAC™ membrane protein degradation technology targets ...

BIOMIND LABS ACCELERATES FDA PATHWAY FOR 5-MEO-DMT CANDIDATE BMND08 AND GRANTS STOCK OPTIONS TORONTO, ON / ACCESS Newswire / December 3, 2025 /Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND ...

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...